Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
26 September 2023 - 6:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2023.
Commission File Number: 001-39530
ImmunoPrecise Antibodies Ltd.
(Exact Name of Registrant as Specified in Charter)
3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F □ Form 40-F ⊠
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
IMMUNOPRECISE ANTIBODIES LTD. |
|
|
|
Date: September 25, 2023 |
By: |
/s/ Brad McConn |
|
Name: |
Brad McConn |
|
Title: |
Chief Financial Officer |
EXHIBIT INDEX
|
|
Date: September 22, 2023 |
3204-4464 Markham St., Victoria, British Columbia, V8Z 7X8, Canada |
To: Alberta Securities Commission
British Columbia Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Manitoba Securities Commission
Ontario Securities Commission
Financial and Consumer Services Commission of New Brunswick
Nova Scotia Securities Commission
The Office of the Superintendent Securities, Consumer, Corporate and Insurance Services Division,
Office of the Attorney General of Prince Edward Island
Office of the Superintendent of Securities, Service Newfoundland & Labrador
Subject: IMMUNOPRECISE ANTIBODIES LTD.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : |
Annual General Meeting |
Record Date for Notice of Meeting : |
October 03, 2023 |
Record Date for Voting (if applicable) : |
October 03, 2023 |
Beneficial Ownership Determination Date : |
October 03, 2023 |
Meeting Date : |
November 09, 2023 |
Meeting Location (if available) : |
Virtual Meeting |
Issuer sending proxy related materials directly to NOBO: |
No |
Issuer paying for delivery to OBO: |
No |
|
Notice and Access (NAA) Requirements: |
NAA for Beneficial Holders |
No |
NAA for Registered Holders |
No |
Voting Security Details:
Description |
CUSIP Number |
ISIN |
COMMON |
45257F200 |
CA45257F2008 |
Sincerely,
IMMUNOPRECISE ANTIBODIES LTD.
ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From Apr 2024 to May 2024
ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From May 2023 to May 2024